静脉血栓栓塞的抗凝固的持续时间
Francis Couturaud1, Nicolas Meneveau2, Marie Antoinette Sevestre3
1CHU Brest, Département de Médecine Interne et Pneumologie, Brest, France; Univ_Brest, INSERM U1304-GETBO, CIC INSERM 1412, F29609 Brest, France; FCRIN INNOVTE network, Saint-Etienne, France.
概括
管理静脉血栓塞栓症 (VTE) 需要仔细考虑抗凝剂的持续时间. 平衡复发风险和出血风险至关重要,特别是在第一次未引起的VTE事件后.
科学领域:
- 血液学 血液学 血液学
- 心血管医学 心血管医学
- 临床血栓形成 临床血栓形成
背景情况:
- 静脉血栓栓塞 (VTE) 是一种普遍且严重的医疗状况,需要抗凝治疗.
- 标准治疗包括至少三个月的抗凝药,以防止VTE复发和长期后果.
- 在初始治疗后,继续或停止抗凝治疗的决定取决于复发性VTE与出血并发症的风险效益分析.
研究的目的:
- 为了解决第一个未引起的VTE的患者确定最佳抗凝剂持续时间的挑战.
- 突出目前对VTE复发和出血风险的预测模型的局限性.
- 探索减少剂量抗凝固策略的安全性和有效性的不确定性.
主要方法:
- 对VTE中抗凝管理的既定指导方针的审查.
- 对VTE复发和出血风险的当前预测分数的分析.
- 讨论关于降低剂量抗凝固药物的现有证据.
主要成果:
- 指导方针建议短期抗凝治疗短暂的VTE原因和无限期治疗复发性或与癌症相关的VTE.
- 由于当前预测工具的可靠性不足,第一次未引起的VTE的决策仍然很复杂.
- 降低剂量抗凝剂的安全性和有效性尚未明确确确立.
结论:
- 目前针对VTE的抗凝管理方法,特别是第一次未引起的事件,存在重大临床挑战.
- 需要改进预测工具,以更好地分层个体患者的复发和出血风险.
- 未来精准医学和以患者为中心的护理方面的进步有望为优化VTE治疗决策提供希望.
更多相关视频
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Venous Return
3.4K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
3.4K
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57


